JESSICA PROVOST: Open Payments
NPI 1659724144 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 26 payments from 10 companies in 2025. Trend: 2023 $669 · 2024 $427 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $182 |
| PFIZER INC. | 5 | $91 |
| Lilly USA, LLC | 4 | $70 |
| Aimmune Therapeutics, Inc. | 1 | $58 |
| Abbott Laboratories | 3 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Amgen Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: Wegovy, PREVNAR 20, VOWST, MOUNJARO, JARDIANCE, FREESTYLE LIBRE 3, Ozempic, ELIQUIS.
Industry payments across OK — which companies pay providers there.
